ICU Medical, Inc. (ICUI)
USD 133.97
(-5.82%)
USD 133.97
(-5.82%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -29.65 Million USD | 60.08% |
| 2022 | -74.28 Million USD | -172.03% |
| 2021 | 103.13 Million USD | 18.72% |
| 2020 | 86.87 Million USD | -14.02% |
| 2019 | 101.03 Million USD | 250.9% |
| 2018 | 28.79 Million USD | -58.05% |
| 2017 | 68.64 Million USD | 8.81% |
| 2016 | 63.08 Million USD | 40.23% |
| 2015 | 44.98 Million USD | 70.82% |
| 2014 | 26.33 Million USD | -34.84% |
| 2013 | 40.41 Million USD | -2.09% |
| 2012 | 41.28 Million USD | -7.58% |
| 2011 | 44.66 Million USD | 44.42% |
| 2010 | 30.92 Million USD | 16.46% |
| 2009 | 26.55 Million USD | 9.29% |
| 2008 | 24.3 Million USD | 5.29% |
| 2007 | 23.07 Million USD | -10.06% |
| 2006 | 25.66 Million USD | 26.57% |
| 2005 | 20.27 Million USD | 305.48% |
| 2004 | 5 Million USD | -77.58% |
| 2003 | 22.29 Million USD | 13.29% |
| 2002 | 19.68 Million USD | 27.91% |
| 2001 | 15.38 Million USD | 30.53% |
| 2000 | 11.78 Million USD | 25.4% |
| 1999 | 9.4 Million USD | 30.56% |
| 1998 | 7.2 Million USD | 26.32% |
| 1997 | 5.7 Million USD | 21.28% |
| 1996 | 4.7 Million USD | 11.9% |
| 1995 | 4.2 Million USD | 44.83% |
| 1994 | 2.9 Million USD | -12.12% |
| 1993 | 3.3 Million USD | -32.65% |
| 1992 | 4.9 Million USD | 63.33% |
| 1991 | 3 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -21.4 Million USD | 45.77% |
| 2024 Q1 | -39.47 Million USD | -130.19% |
| 2023 FY | -29.65 Million USD | 60.08% |
| 2023 Q1 | -9.81 Million USD | 36.84% |
| 2023 Q4 | -17.14 Million USD | -336.9% |
| 2023 Q3 | 7.23 Million USD | 172.86% |
| 2023 Q2 | -9.93 Million USD | -1.24% |
| 2022 Q2 | -7.47 Million USD | 80.37% |
| 2022 FY | -74.28 Million USD | -172.03% |
| 2022 Q4 | -15.53 Million USD | -17.63% |
| 2022 Q3 | -13.2 Million USD | -76.72% |
| 2022 Q1 | -38.06 Million USD | -291.06% |
| 2021 Q2 | 28.39 Million USD | 19.67% |
| 2021 Q3 | 31.08 Million USD | 9.45% |
| 2021 FY | 103.13 Million USD | 18.72% |
| 2021 Q4 | 19.92 Million USD | -35.89% |
| 2021 Q1 | 23.73 Million USD | -9.22% |
| 2020 FY | 86.87 Million USD | -14.02% |
| 2020 Q1 | 16.83 Million USD | -18.44% |
| 2020 Q2 | 18.9 Million USD | 12.32% |
| 2020 Q3 | 24.98 Million USD | 32.15% |
| 2020 Q4 | 26.14 Million USD | 4.63% |
| 2019 Q3 | 26.56 Million USD | 16.34% |
| 2019 Q4 | 20.64 Million USD | -22.29% |
| 2019 Q2 | 22.83 Million USD | -26.34% |
| 2019 FY | 101.03 Million USD | 250.9% |
| 2019 Q1 | 30.99 Million USD | 521.45% |
| 2018 Q4 | -7.35 Million USD | -3458.45% |
| 2018 Q1 | 4.87 Million USD | -90.19% |
| 2018 Q2 | 31.05 Million USD | 537.01% |
| 2018 Q3 | 219 Thousand USD | -99.29% |
| 2018 FY | 28.79 Million USD | -58.05% |
| 2017 Q1 | 55.86 Million USD | 487.29% |
| 2017 Q4 | 49.7 Million USD | 36447.79% |
| 2017 Q3 | 136 Thousand USD | 100.37% |
| 2017 Q2 | -37.06 Million USD | -166.34% |
| 2017 FY | 68.64 Million USD | 8.81% |
| 2016 Q2 | 16.6 Million USD | -8.56% |
| 2016 FY | 63.08 Million USD | 40.23% |
| 2016 Q4 | 9.51 Million USD | -49.42% |
| 2016 Q3 | 18.8 Million USD | 13.25% |
| 2016 Q1 | 18.16 Million USD | 232.42% |
| 2015 FY | 44.98 Million USD | 70.82% |
| 2015 Q4 | 5.46 Million USD | -66.41% |
| 2015 Q1 | 9.68 Million USD | 31.39% |
| 2015 Q3 | 16.26 Million USD | 19.87% |
| 2015 Q2 | 13.57 Million USD | 40.1% |
| 2014 Q3 | 6.42 Million USD | 9.36% |
| 2014 FY | 26.33 Million USD | -34.84% |
| 2014 Q1 | 6.65 Million USD | -50.07% |
| 2014 Q2 | 5.87 Million USD | -11.7% |
| 2014 Q4 | 7.37 Million USD | 14.69% |
| 2013 Q4 | 13.33 Million USD | 20.83% |
| 2013 Q3 | 11.03 Million USD | 49.78% |
| 2013 Q2 | 7.36 Million USD | -15.18% |
| 2013 Q1 | 8.68 Million USD | -29.64% |
| 2013 FY | 40.41 Million USD | -2.09% |
| 2012 FY | 41.28 Million USD | -7.58% |
| 2012 Q2 | 9.14 Million USD | 20.37% |
| 2012 Q3 | 12.18 Million USD | 33.22% |
| 2012 Q4 | 12.34 Million USD | 1.27% |
| 2012 Q1 | 7.6 Million USD | -57.4% |
| 2011 Q2 | 9.49 Million USD | 17.59% |
| 2011 FY | 44.66 Million USD | 44.42% |
| 2011 Q4 | 17.84 Million USD | 92.66% |
| 2011 Q3 | 9.26 Million USD | -2.44% |
| 2011 Q1 | 8.07 Million USD | -19.16% |
| 2010 Q1 | 4.25 Million USD | -42.73% |
| 2010 Q4 | 9.98 Million USD | 11.26% |
| 2010 FY | 30.92 Million USD | 16.46% |
| 2010 Q3 | 8.97 Million USD | 16.36% |
| 2010 Q2 | 7.71 Million USD | 81.27% |
| 2009 Q4 | 7.43 Million USD | 17.49% |
| 2009 FY | 26.55 Million USD | 9.29% |
| 2009 Q1 | 7.06 Million USD | -21.4% |
| 2009 Q2 | 5.74 Million USD | -18.71% |
| 2009 Q3 | 6.32 Million USD | 10.16% |
| 2008 FY | 24.3 Million USD | 5.29% |
| 2008 Q4 | 8.98 Million USD | 17.53% |
| 2008 Q2 | 4.77 Million USD | 64.67% |
| 2008 Q1 | 2.89 Million USD | -51.8% |
| 2008 Q3 | 7.64 Million USD | 60.21% |
| 2007 Q2 | 2.54 Million USD | -74.08% |
| 2007 FY | 23.07 Million USD | -10.06% |
| 2007 Q1 | 9.81 Million USD | 43.08% |
| 2007 Q4 | 6.01 Million USD | 27.75% |
| 2007 Q3 | 4.7 Million USD | 85.02% |
| 2006 Q1 | 6.36 Million USD | 19.86% |
| 2006 Q3 | 6.14 Million USD | -2.38% |
| 2006 Q4 | 6.86 Million USD | 11.69% |
| 2006 FY | 25.66 Million USD | 26.57% |
| 2006 Q2 | 6.29 Million USD | -1.16% |
| 2005 Q2 | 4.73 Million USD | 7.29% |
| 2005 FY | 20.27 Million USD | 305.48% |
| 2005 Q4 | 5.31 Million USD | -8.54% |
| 2005 Q1 | 4.41 Million USD | 391.74% |
| 2005 Q3 | 5.8 Million USD | 22.54% |
| 2004 Q2 | 3.41 Million USD | -17.63% |
| 2004 Q3 | -1.03 Million USD | -130.38% |
| 2004 Q1 | 4.14 Million USD | -42.12% |
| 2004 FY | 5 Million USD | -77.58% |
| 2004 Q4 | -1.51 Million USD | -46.14% |
| 2003 Q1 | 7.07 Million USD | 20.14% |
| 2003 FY | 22.29 Million USD | 13.29% |
| 2003 Q4 | 7.15 Million USD | 71.33% |
| 2003 Q2 | 3.89 Million USD | -44.85% |
| 2003 Q3 | 4.17 Million USD | 7.08% |
| 2002 Q2 | 4.99 Million USD | 10.5% |
| 2002 FY | 19.68 Million USD | 27.91% |
| 2002 Q4 | 5.88 Million USD | 37.63% |
| 2002 Q3 | 4.27 Million USD | -14.45% |
| 2002 Q1 | 4.52 Million USD | -5.2% |
| 2001 Q3 | 3.31 Million USD | -11.82% |
| 2001 Q2 | 3.76 Million USD | 6.54% |
| 2001 Q4 | 4.77 Million USD | 43.75% |
| 2001 Q1 | 3.53 Million USD | -7.59% |
| 2001 FY | 15.38 Million USD | 30.53% |
| 2000 Q2 | 2.97 Million USD | 3.41% |
| 2000 Q4 | 3.82 Million USD | 80.08% |
| 2000 FY | 11.78 Million USD | 25.4% |
| 2000 Q1 | 2.87 Million USD | -4.27% |
| 2000 Q3 | 2.12 Million USD | -28.52% |
| 1999 Q4 | 3 Million USD | 57.89% |
| 1999 Q2 | 2.2 Million USD | 0.0% |
| 1999 FY | 9.4 Million USD | 30.56% |
| 1999 Q3 | 1.9 Million USD | -13.64% |
| 1999 Q1 | 2.2 Million USD | 10.0% |
| 1998 Q3 | 1.8 Million USD | 5.88% |
| 1998 Q1 | 1.7 Million USD | 0.0% |
| 1998 FY | 7.2 Million USD | 26.32% |
| 1998 Q4 | 2 Million USD | 11.11% |
| 1998 Q2 | 1.7 Million USD | 0.0% |
| 1997 Q3 | 1.4 Million USD | 7.69% |
| 1997 Q2 | 1.3 Million USD | 0.0% |
| 1997 Q1 | 1.3 Million USD | 44.44% |
| 1997 FY | 5.7 Million USD | 21.28% |
| 1997 Q4 | 1.7 Million USD | 21.43% |
| 1996 Q2 | 1.3 Million USD | -18.75% |
| 1996 FY | 4.7 Million USD | 11.9% |
| 1996 Q3 | 1 Million USD | -23.08% |
| 1996 Q4 | 900 Thousand USD | -10.0% |
| 1996 Q1 | 1.6 Million USD | -5.88% |
| 1995 Q3 | 900 Thousand USD | 0.0% |
| 1995 Q4 | 1.7 Million USD | 88.89% |
| 1995 Q2 | 900 Thousand USD | 28.57% |
| 1995 FY | 4.2 Million USD | 44.83% |
| 1995 Q1 | 700 Thousand USD | 0.0% |
| 1994 FY | 2.9 Million USD | -12.12% |
| 1994 Q1 | 1.1 Million USD | 0.0% |
| 1994 Q2 | 800 Thousand USD | -27.27% |
| 1994 Q3 | 300 Thousand USD | -62.5% |
| 1994 Q4 | 700 Thousand USD | 133.33% |
| 1993 FY | 3.3 Million USD | -32.65% |
| 1993 Q4 | 1.1 Million USD | 120.0% |
| 1993 Q3 | 500 Thousand USD | -16.67% |
| 1993 Q2 | 600 Thousand USD | -45.45% |
| 1993 Q1 | 1.1 Million USD | 0.0% |
| 1992 Q1 | 1.7 Million USD | 1600.0% |
| 1992 Q2 | 900 Thousand USD | -47.06% |
| 1992 Q3 | 1.3 Million USD | 44.44% |
| 1992 Q4 | 1.1 Million USD | -15.38% |
| 1992 FY | 4.9 Million USD | 63.33% |
| 1991 Q1 | 700 Thousand USD | 0.0% |
| 1991 FY | 3 Million USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | -85.71% |
| 1991 Q3 | 2.2 Million USD | 2100.0% |
| 1991 Q4 | 100 Thousand USD | -95.45% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 53.169% |
| AngioDynamics, Inc. | -184.34 Million USD | 83.914% |
| AtriCure, Inc. | -30.43 Million USD | 2.572% |
| Avinger, Inc. | -18.32 Million USD | -61.872% |
| Azenta, Inc. | -14.25 Million USD | -108.003% |
| BioLife Solutions, Inc. | -66.42 Million USD | 55.357% |
| The Cooper Companies, Inc. | 294.2 Million USD | 110.08% |
| Daxor Corporation | 280.64 Thousand USD | 10666.918% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | -95.124% |
| Femasys Inc. | -14.24 Million USD | -108.147% |
| GlucoTrack, Inc. | -7.09 Million USD | -317.853% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -768.375% |
| Hologic, Inc. | 789.5 Million USD | 103.756% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 101.649% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -115.813% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 198.505% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -345.041% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -345.041% |
| Masimo Corporation | 81.5 Million USD | 136.387% |
| Microbot Medical Inc. | -10.74 Million USD | -176.117% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 355.088% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 131.411% |
| Nephros, Inc. | -1.57 Million USD | -1782.857% |
| NovoCure Limited | -207.04 Million USD | 85.677% |
| NEXGEL, Inc. | -3.15 Million USD | -839.341% |
| NEXGEL, Inc. | -3.15 Million USD | -839.341% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 68.725% |
| OraSure Technologies, Inc. | 53.65 Million USD | 155.27% |
| Pro-Dex, Inc. | 2.12 Million USD | 1494.217% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 29.744% |
| Predictive Oncology Inc. | -13.98 Million USD | -112.064% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -904.785% |
| QuidelOrtho Corporation | -10.1 Million USD | -193.614% |
| Repligen Corporation | 41.57 Million USD | 171.325% |
| Sanara MedTech Inc. | -4.3 Million USD | -589.139% |
| STAAR Surgical Company | 21.34 Million USD | 238.919% |
| Sharps Technology, Inc. | -9.84 Million USD | -201.322% |
| Utah Medical Products, Inc. | 16.63 Million USD | 278.269% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 77.534% |
| Jin Medical International Ltd. | 2.87 Million USD | 1130.321% |